Skip to main content
Home logo

User account menu

Log inSearch

Main navigation

  • Home
  • Data Sources
  • Studies
  • Institutions
  • Networks
  • What's new
  • Support
  1. Home

ConcepTION

01/02/2024
01/02/2024
Network
Download as PDF

Page content

  • Network identification
  • Network description
  • Network details
  • Contact
  • Institutions that are part of this network
Network identification

PURI

https://redirect.ema.europa.eu/resource/2221112

Network ID

2221112

Network name and Acronym

ConcepTION

Network website

https://www.imi.europa.eu/projects-results/project-factsheets/conception

ENCePP partner

No

Institutions that are part of this network

Aarhus University & Aarhus University Hospital DEPARTMENT OF CLINICAL EPIDEMIOLOGY
Bordeaux PharmacoEpi, University of Bordeaux
Drugs and Pregnancy, Finnish Institute for Health and Welfare (THL)

Studies conducted by the network

Analysis of pregnancy pharmacovigilance data in spontaneous reports, and literature, (Individual Case Safety Reports originating from published case series, non-interventional studies and patient support programmes); demonstration study 2.5.1 of the ConcePTION project
Building a pregnancy pharmacovigilance model for the future: Can pregnancy data collected by ConcePTION partners be analysed using common standards developed by the ConcePTION project?
Data characterization of population-based data sources: ConcePTION pipeline
Demonstrating solutions for studying intermittent medication exposures in diseases with episodic manifestations during pregnancy: application to medication for migraine in pregnancy
Levocetirizine/cetirizine levels in human milk – an observational, clinical study among breastfeeding women
Long-term investigation following exposure to individual medicines in utero: The LIFETIME system
Methods for controlling by indication for prescriptions: application to medications for neuropathic pain
Novel statistics to handle rare diseases and small sample sizes using Bayesian techniques: Application to Multiple Sclerosis (MS) and Systemic Lupus Erythematosus (SLE) in pregnancy
Studying drug exposure when disease is measured through accurate identification of an incident case: application to breast cancer in pregnancy (ConcePTION breast cancer demo)

Share this page

HMA-EMA Catalogues of real-world data sources and studies

Privacy

Privacy policy
Cookies
Legal notice

Contact

Contact us